FDA approves several Biosense Webster devices for fluoroscopy-free ablation procedures

The ThermoCool SmartTouch SF catheter from Biosense Webster

The ThermoCool SmartTouch SF catheter from Biosense Webster, one of multiple devices from the company's cardiac ablation portfolio now approved to be used as part of a zero-fluoroscopy workflow.

Using these devices as part of a zero-fluoroscopy workflow, which replaces X-rays with an alternative modality such as ultrasound, limits radiation exposure and the use of burdensome protective equipment.